Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Mar:65:103260.
doi: 10.1016/j.ebiom.2021.103260. Epub 2021 Feb 24.

Non-communicable diseases pandemic and precision medicine: Is Africa ready?

Affiliations
Review

Non-communicable diseases pandemic and precision medicine: Is Africa ready?

Tinashe Chikowore et al. EBioMedicine. 2021 Mar.

Abstract

Non-communicable diseases (NCDs) kill more than 41 million people every year, accounting for 71% of all deaths globally. The prevalence of NCDs is estimated to be higher than that of infectious diseases in Africa by 2030. Precision medicine may help with early identification of cases, resulting in timely prevention and improvement in the efficacy of treatments. However, Africa has been lagging behind in genetic research, a key component of the precision medicine initiative. A number of genomic research initiatives which could lead to translational genomics are emerging on the African continent which includes the Non-communicable Diseases Genetic Heritage Study (NCDGHS) and the Men of African Descent and Carcinoma of the Prostate (MADCaP) Network. These offer a promise that precision medicine can be applied in African countries. This review evaluates the advances of genetic studies for cancer, hypertension, type 2 diabetes and body mass index (BMI) in Africa.

Keywords: Africa; Cancer; Diabetes; Genetics; Hypertension; Obesity.

PubMed Disclaimer

Conflict of interest statement

Declaration of Interests We have none to declare.

Figures

Fig 1
Fig. 1
Schematic outline of the progress, development and support of genetics research in Africa. Human Hereditary and Health in Africa (H3Africa) is ongoing and has recruited about 99,408 participants, African Partnerships of Chronic Disease Research (APCDR) has 7000 participants, and the Non-communicable Diseases Genetic Heritage Study (NCD-GHS) is planning to recruit 100,000 participants. The South African Human Genome Project (SAHGP) was funded by the government of South Africa.
Fig 2
Fig. 2
Number of candidate genetic studies of selected NCDs that have been conducted in African countries from 2009 to 2019.DRC, Democratic Republic of Congo.
Fig 3
Fig. 3
NCDs and genetics consortia coverage in Africa. The Human Hereditary and Health in Africa (H3Africa), is the largest and widest consortium in Africa, to date (over 30 African countries). Non-communicable Diseases Genetic Heritage Study (NCD-GHS) is based in Nigeria. The African Partnerships of Chronic Disease Research (APCDR) is in Uganda, the Evolving Risk Factors for Cancers in African Populations (ERICA-SA) is underway in South Africa, the Africa Esophageal Cancer Consortium (AfrECC) is underway in six countries, and the Men of African Descent and Carcinoma of the Prostate (MADCaP) recruitment is underway in four countries. The consortia coverage above is based on the study sites of the respective consortia.

References

    1. Dicker D, Nguyen G, Abate D. Global, regional, and national age-sex-specific mortality and life expectancy, 1950–2017: a systematic analysis for the global burden of disease study 2017. Lancet. 2018;392(10159):1684–1735. - PMC - PubMed
    1. Bigna JJ, Noubiap JJ. The rising burden of non-communicable diseases in sub-Saharan Africa. Lancet Global Health. 2019;7(10):e1295–e12e6. - PubMed
    1. Parkin DM, Bray F, Ferlay J, Jemal A. Cancer in Africa 2012. Cancer Epidemiol Biomarkers Prev. 2014;23(6):953–966. - PubMed
    1. Patel P, Rose CE, Collins PY. Noncommunicable diseases among HIV-infected persons in low-income and middle-income countries: a systematic review and meta-analysis. AIDS (London, England) 2018;32(Suppl 1):S5. - PMC - PubMed
    1. Arena R, Ozemek C, Laddu D. Applying precision medicine to healthy living for the prevention and treatment of cardiovascular disease. Curr Probl Cardiol. 2018;43(12):448–483. - PubMed

LinkOut - more resources